It was the right move for all fiscal conservatives. It is also the right move for anyone who listens to the will of the people: nearly 2/3 opposing the Health Care bill.
Several leading European and Canadian health economists, physicians and scholars—in Washington recently for the Galen Institute’s conference, "Lessons from Abroad for Health Reform in the US"—met with analysts from the Heritage Foundation and other conservative think-tank leaders.
They wanted to explain why Americans should be concerned when officials push for government-controlled, universal health care coverage that includes innocuous-sounding but largely intrusive and prohibitive health measures.
"We were told single-payer health care would be a true liberation for Canada when they enacted it 40 years ago, and the opposite has become true," says Brian Lee Crowley, president of the Atlantic Institute for Market Studies in Canada.
Not only do Canadians face extraordinary wait times to get specialized treatments (the average wait time from getting a referral from a general practitioner to receiving a treatment was 17.3 weeks in 2008), but they also have limited access to new drugs, thanks in part to the country’s "comparative effectiveness" body known as the Common Drug Review, says Brett Skinner with the Fraser Institute.
Institut economique Molinari
Dated: 7/4/09
Several leading European and Canadian health economists, physicians and scholars—in Washington recently for the Galen Institute’s conference, "Lessons from Abroad for Health Reform in the US"—met with analysts from the Heritage Foundation and other conservative think-tank leaders.
They wanted to explain why Americans should be concerned when officials push for government-controlled, universal health care coverage that includes innocuous-sounding but largely intrusive and prohibitive health measures.
"We were told single-payer health care would be a true liberation for Canada when they enacted it 40 years ago, and the opposite has become true," says Brian Lee Crowley, president of the Atlantic Institute for Market Studies in Canada.
Not only do Canadians face extraordinary wait times to get specialized treatments (the average wait time from getting a referral from a general practitioner to receiving a treatment was 17.3 weeks in 2008), but they also have limited access to new drugs, thanks in part to the country’s "comparative effectiveness" body known as the Common Drug Review, says Brett Skinner with the Fraser Institute.
Visit National Strike - January 20, 2010